stoxline Quote Chart Rank Option Currency Glossary
Singular Genomics Systems, Inc. (OMIC)
8  -0.05 (-0.62%)    07-18 16:00
Open: 8.05
High: 8.05
Volume: 3,643
Pre. Close: 8.05
Low: 8
Market Cap: 20(M)
Technical analysis
2024-07-18 3:52:41 PM
Short term     
Mid term     
Targets 6-month :  12.27 1-year :  14.44
Resists First :  10.5 Second :  12.36
Pivot price 8.29
Supports First :  7.5 Second :  6.24
MAs MA(5) :  8.4 MA(20) :  8.67
MA(100) :  12.31 MA(250) :  13.37
MACD MACD :  -0.6 Signal :  -0.7
%K %D K(14,3) :  16.4 D(3) :  19.4
RSI RSI(14): 41.3
52-week High :  29.7 Low :  7.5
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ OMIC ] has closed above bottom band by 33.9%. Bollinger Bands are 40.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 8.23 - 8.27 8.27 - 8.31
Low: 8.12 - 8.17 8.17 - 8.2
Close: 8.15 - 8.22 8.22 - 8.28
Company Description

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California.

Headline News

Mon, 15 Jul 2024
Singular Genomics Regains Compliance with Nasdaq Minimum Bid Price Requirement - StockTitan

Wed, 10 Jul 2024
Singular Genomics Systems (NASDAQ:OMIC) Price Target Cut to $6.50 by Analysts at The Goldman Sachs Group - Defense World

Thu, 27 Jun 2024
Singular Genomics Systems (NASDAQ:OMIC) Shares Gap Down to $11.10 - MarketBeat

Fri, 21 Jun 2024
Singular Genomics Announces 1-for-30 Reverse Stock Split - StockTitan

Tue, 14 May 2024
Singular Genomics Systems, Inc. (OMIC) Q1 2024 Earnings Call Transcript - Seeking Alpha

Wed, 20 Mar 2024
Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2023 Earnings Call Transcript - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical - Instruments & Supplies
Shares Out 0 (M)
Shares Float 2 (M)
Held by Insiders 1.55e+006 (%)
Held by Institutions 14 (%)
Shares Short 14 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -9.864e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -6 %
Return on Assets (ttm) 74.2 %
Return on Equity (ttm) -23.5 %
Qtrly Rev. Growth 2.49e+006 %
Gross Profit (p.s.) -35.89
Sales Per Share -35.64
EBITDA (p.s.) 0
Qtrly Earnings Growth -39.3 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -79 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio -0.1
Price to Book value 0
Price to Sales -0.23
Price to Cash Flow 0.17
Stock Dividends
Dividend 0
Forward Dividend 7230
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android